Advertisement
Screener

20/20 BIOLABS, INC. (AIDX) Graph

AIDX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $730.57K; Revenue including tax $730.57K; Cost of revenue $425.84K; Research and development $257.63K.
  • 2026-03-31: Revenue $353.38K; Revenue including tax $353.38K; Cost of revenue $290.49K; Research and development $153.48K.
  • 2025-06-30: Revenue $535.06K; Revenue including tax $535.06K; Cost of revenue $371.80K; Research and development $194.12K.
  • 2025-03-31: Revenue $553.82K; Revenue including tax $553.82K; Cost of revenue $388.02K; Research and development $136.83K.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AIDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Bio Check$34.62KOne Test$695.95KRevenue$730.57KCost of revenue$425.84KGross profit$304.73KOperating expenses$1.55MOperating income-$1.24MOther income, net-$115.00Research & development$257.63KSelling, general& administrative$1.29MNet income-$1.51M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$730.57K$730.57K$425.84K$257.63K$1.29M$1.55M-$1.51M
2026-03-31$353.38K$353.38K$290.49K$153.48K$1.35M$1.51M-$2.17M
2025-06-30$535.06K$535.06K$371.80K$194.12K$814.81K$1.01M-$840.93K
2025-03-31$553.82K$553.82K$388.02K$136.83K$801.14K$937.98K-$764.58K

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$1.08M$1.08M$716.34K$411.11K$2.64M$3.06M-$3.68M
2025-06-30$1.09M$1.09M$759.82K$330.95K$1.62M$1.95M-$1.61M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2025-12-31$2.05M$2.05M$1.44M$592.57K$3.34M$3.94M-$3.74M
2024-12-31$1.75M$1.75M$1.39M$1.26M$4.76M$6.04M-$5.55M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGENOMICS INC (NEO)United States$2.514B-35.96